Germany· DE-A57-821ad9748a4091d9
Erythrocin Neo
A medicinal product containing erythromycin ethylsuccinate, registered in Germany by Amdipharm Limited.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Erythromycin Ethylsuccinate
- Manufacturer
- Amdipharm Limited
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Erythromycin ethylsuccinate in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomErythromycin ethyl succinate 125mg/5ml oral suspensionSigma Pharmaceuticals Plc
- United StatesE.E.SREMEDYREPACK INC.
- FinlandAbboticinAbbott Scandinavia AB
- BelgiumErythrocine 250 mg/5 mlAmdipharm
- IrelandPrimacine 125 mg/5 ml Granules for Oral SuspensionPinewood Laboratories Ltd
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Belgium · Erythroforte
- Denmark · Abboticin, Abboticin Novum
- Spain · Eritromicina Normon, Pantomicina
- France · Ery Enfants, Erythrocine
- United Kingdom (Northern Ireland) · Erythromycin, Erythromycin Amdipharm Uk
- Ireland · Erythroped, Erythroped Pi
- Luxembourg · Erythrocine, Erythroforte
- Malta · Primacine
- Norway · Abboticin Es
- Portugal · E.S.E. 500, Eritrocina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eaf90f36-9fd0-4679-ac58-004f4cb9675c GET /v1/drugs/eaf90f36-9fd0-4679-ac58-004f4cb9675c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Erythromycin Ethylsuccinate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about erythromycin ethylsuccinate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.